title: [Influenza vaccination of cancer patients].
abstract: Influenza infection adds to the morbidity and mortality in cancer patients. This paper reviews studies on the ability of adult cancer patients to develop a protective immunological response to influenza vaccination. The studies showed that patients undergoing chemotherapy were able to develop an immunological response and seroprotection. The ideal administration time in the course of a chemotherapy treatment was unclear, but the longest time from chemotherapy was preferred. Repeated vaccination may be beneficial. Influenza vaccination is safe, inexpensive and easily available.
authors.affiliation: Onkologisk Afdeling, Herlev Hospital, Herlev Ringvej 75, 2730 Herlev. anders.mellemgaard@regionh.dk.
authors.forename: Anna
authors.initials: A
authors.lastname: Andreeva
authors.forename: Anne-Cathrine Bareid
authors.initials: AC
authors.lastname: Østby
authors.forename: Anders
authors.initials: A
authors.lastname: Mellemgaard
mesh_terms: D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control*; D009369:Neoplasms / Q000150:complications / Q000276:immunology*
chemical_list: D007252:Influenza Vaccines